Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01592370 |
|---|---|
| Brief Title: | An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma |
| First Submitted : | May 3, 2012 |
| First Submitted that Met QC Criteria : | May 4, 2012 |
| First Posted : | May 7, 2012 (Estimate) |
| Results First Submitted : | September 24, 2021 |
| Results First Submitted that Met QC Criteria : | January 27, 2022 |
| Results First Posted : | February 17, 2022 |
| Last Update Submitted that Met QC Criteria : | September 11, 2023 |
| Last Update Posted : | September 13, 2023 |